Clinical trial / 2022
Turmeric combined with piperine reduced MDA and ferritin levels more effectively than turmeric alone in hemodialysis patients.
Hemodialysis patients aged 20-75 were randomized to receive 12 weeks of turmeric alone (3 g/day) or turmeric with piperine (3 g turmeric + 2 mg piperine/day). The turmeric/piperine group showed significantly greater reductions in MDA [-0.08(-0.14/0.01) nmol/mL vs -0.003(-0.10/0.26) nmol/mL, p=0.003] and ferritin [-193.80 ± 157.29 mg/mL vs 51.99 ± 293.25 mg/mL, p=0.018] compared to turmeric alone. Additionally, GPx activity decreased in the turmeric group (p=0.029), while no changes were observed for CAT, GR, or hs-CRP.
- Study type
- Randomized, double-blind clinical trial
- Who was studied
- Hemodialysis patients aged 20-75 years
- What was measured
- Malondialdehyde (MDA), catalase, glutathione peroxidase (GPx), glutathione reductase, hs-CRP, and ferritin
THE PAPER
Turmeric supplementation with piperine is more effective than turmeric alone in attenuating oxidative stress and inflammation in hemodialysis patients: A randomized, double-blind clinical trial.
Freitas E Silva-Santana NC, Rodrigues HCN, Pereira Martins TF, Braga CC, Silva MAC, Carlos da Cunha L, de Souza Freitas ATV, Costa NA, Peixoto MDRG. Free Radic Biol Med, 2022.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.